Moriyama Tatsuya, Kishimoto Keiko, Nagai Kiyoko, Urade Reiko, Ogawa Tadashi, Utsumi Shigeru, Maruyama Nobuyuki, Maebuchi Motohiro
Graduate School of Agriculture, Kyoto University, Japan.
Biosci Biotechnol Biochem. 2004 Feb;68(2):352-9. doi: 10.1271/bbb.68.352.
The purpose of this study was to discover the effects of soybean beta-conglycinin (7S-globulin) and glycinin (11S-globulin) on serum lipid levels and metabolism in the livers of normal and genetically obese mice. Male normal (ICR) and obese (KK-Ay) mice were fed ad libitum high fat diets for two weeks, followed by a 2-week restriction of diet (2 g diet/mouse/day) containing 20% casein, soybean beta-conglycinin, or soybean glycinin, and then sacrificed immediately. Serum triglyceride (TG), glucose, and insulin levels of beta-conglycinin-fed mice were lower than in casein- and glycinin-fed mice of both strains. In order to analyze the related events to these effects, enzyme activities and relative mRNA levels of lipid metabolism-related proteins were measured. The activities of two enzymes related to fatty acid beta-oxidation were higher while that of fatty acid synthase was lower in livers of beta-conglycinin-fed mice than of casein-fed both mice. Messenger RNA levels of acyl-CoA oxidase (fatty acid beta-oxidation related enzyme) were significantly higher in livers of beta-conglycinin-fed mice than of both casein-fed mice. On the contrary, mRNA levels of SREBP-1 and 2 tended to be lowered in livers of soy protein-fed mice than of both casein-fed mice. Fecal excretion of TG was higher in beta-conglycinin-fed mice than in casein-fed mice. Our results demonstrated that the soy beta-conglycinin diet reduced serum TG levels by acceleration of beta-oxidation, suppression of fatty acid synthase and/or increased TG fecal excretion, and also diminished serum glucose and insulin levels. Some of these events might be caused at the transcriptional levels, judged from the result that relative messenger RNA levels of lipid metabolism-related proteins were altered. These results suggest that soy beta-conglycinin could be a potentially useful dietary protein source for the prevention of hypertriglyceridemia, hyperinsulinemia, and hyperglycemia, which are recognized as risk factors for atherosclerosis.
本研究的目的是探究大豆β-伴大豆球蛋白(7S球蛋白)和大豆球蛋白(11S球蛋白)对正常小鼠和遗传性肥胖小鼠血清脂质水平及肝脏代谢的影响。雄性正常(ICR)小鼠和肥胖(KK-Ay)小鼠自由采食高脂饮食两周,随后限制饮食两周(每只小鼠每天2克饮食),饮食中含有20%的酪蛋白、大豆β-伴大豆球蛋白或大豆球蛋白,然后立即处死。β-伴大豆球蛋白喂养的小鼠血清甘油三酯(TG)、葡萄糖和胰岛素水平低于两种品系的酪蛋白和大豆球蛋白喂养的小鼠。为了分析与这些效应相关的事件,测定了脂质代谢相关蛋白的酶活性和相对mRNA水平。β-伴大豆球蛋白喂养的小鼠肝脏中与脂肪酸β氧化相关的两种酶的活性较高,而脂肪酸合酶的活性较低,相比于酪蛋白喂养的两种小鼠。β-伴大豆球蛋白喂养的小鼠肝脏中酰基辅酶A氧化酶(脂肪酸β氧化相关酶)的mRNA水平显著高于酪蛋白喂养的两种小鼠。相反,大豆蛋白喂养的小鼠肝脏中SREBP-1和2的mRNA水平相比于酪蛋白喂养的两种小鼠有降低趋势。β-伴大豆球蛋白喂养的小鼠粪便中TG的排泄量高于酪蛋白喂养的小鼠。我们的结果表明,大豆β-伴大豆球蛋白饮食通过加速β氧化、抑制脂肪酸合酶和/或增加粪便中TG排泄来降低血清TG水平,同时也降低了血清葡萄糖和胰岛素水平。从脂质代谢相关蛋白的相对mRNA水平发生改变的结果判断,其中一些事件可能在转录水平上引起。这些结果表明,大豆β-伴大豆球蛋白可能是预防高甘油三酯血症、高胰岛素血症和高血糖症的潜在有用的膳食蛋白质来源,这些病症被认为是动脉粥样硬化的危险因素。